Literature DB >> 27841882

Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation.

Takashi Shingu1, Allen L Ho2, Liang Yuan1, Xin Zhou1, Congxin Dai1, Siyuan Zheng3,4, Qianghu Wang3,4, Yi Zhong5, Qing Chang6, James W Horner6, Brandon D Liebelt7,8, Yu Yao9, Baoli Hu1, Yiwen Chen4, Gregory N Fuller10, Roeland G W Verhaak3,4, Amy B Heimberger7, Jian Hu1.   

Abstract

Stem cells, including cancer stem cells (CSCs), require niches to maintain stemness, yet it is unclear how CSCs maintain stemness in the suboptimal environment outside their niches during invasion. Postnatal co-deletion of Pten and Trp53 in mouse neural stem cells (NSCs) leads to the expansion of these cells in their subventricular zone (SVZ) niches but fails to maintain stemness outside the SVZ. We discovered that Qki is a major regulator of NSC stemness. Qk deletion on a Pten-/-; Trp53-/- background helps NSCs maintain their stemness outside the SVZ in Nes-CreERT2; QkL/L; PtenL/L; Trp53L/L mice, which develop glioblastoma with a penetrance of 92% and a median survival time of 105 d. Mechanistically, Qk deletion decreases endolysosome-mediated degradation and enriches receptors essential for maintaining self-renewal on the cytoplasmic membrane to cope with low ligand levels outside niches. Thus, downregulation of endolysosome levels by Qki loss helps glioma stem cells (GSCs) maintain their stemness in suboptimal environments outside their niches.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27841882      PMCID: PMC5453714          DOI: 10.1038/ng.3711

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  47 in total

Review 1.  Brain tumour stem cells.

Authors:  Angelo L Vescovi; Rossella Galli; Brent A Reynolds
Journal:  Nat Rev Cancer       Date:  2006-06       Impact factor: 60.716

Review 2.  New implications for the QUAKING RNA binding protein in human disease.

Authors:  Carol Anne Chénard; Stéphane Richard
Journal:  J Neurosci Res       Date:  2008-02-01       Impact factor: 4.164

Review 3.  Adult neurogenesis in the mammalian brain: significant answers and significant questions.

Authors:  Guo-Li Ming; Hongjun Song
Journal:  Neuron       Date:  2011-05-26       Impact factor: 17.173

4.  Post-transcriptional repression of FOXO1 by QKI results in low levels of FOXO1 expression in breast cancer cells.

Authors:  Fang Yu; Liang Jin; Guodong Yang; Lin Ji; Feng Wang; Zifan Lu
Journal:  Oncol Rep       Date:  2013-12-31       Impact factor: 3.906

5.  STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA.

Authors:  An-Jou Chen; Ji-Hye Paik; Hailei Zhang; Sachet A Shukla; Richard Mortensen; Jian Hu; Haoqiang Ying; Baoli Hu; Jessica Hurt; Natalie Farny; Caroline Dong; Yonghong Xiao; Y Alan Wang; Pamela A Silver; Lynda Chin; Shobha Vasudevan; Ronald A Depinho
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

6.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

7.  Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes.

Authors:  Thomas S Jacques; Alexander Swales; Monika J Brzozowski; Nico V Henriquez; Jacqueline M Linehan; Zaman Mirzadeh; Catherine O' Malley; Heike Naumann; Arturo Alvarez-Buylla; Sebastian Brandner
Journal:  EMBO J       Date:  2009-11-19       Impact factor: 11.598

8.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Authors:  Zhizhong Li; Shideng Bao; Qiulian Wu; Hui Wang; Christine Eyler; Sith Sathornsumetee; Qing Shi; Yiting Cao; Justin Lathia; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

9.  QKI impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2.

Authors:  Wei Lu; Feixue Feng; Jinke Xu; Xiaozhao Lu; Shan Wang; Lifeng Wang; Huanyu Lu; Mengying Wei; Guodong Yang; Li Wang; Zifan Lu; Yanpu Liu; Xiaoying Lei
Journal:  Cancer Biol Ther       Date:  2014-06-11       Impact factor: 4.742

10.  Downregulation of tumor suppressor QKI in gastric cancer and its implication in cancer prognosis.

Authors:  Yongqian Bian; Li Wang; Huanyu Lu; Guodong Yang; Zhang Zhang; Haiyan Fu; Xiaozhao Lu; Mengying Wei; Jianyong Sun; Qingchuan Zhao; Guanglong Dong; Zifan Lu
Journal:  Biochem Biophys Res Commun       Date:  2012-04-30       Impact factor: 3.575

View more
  40 in total

1.  Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles.

Authors:  Gabriela D A Guardia; Bruna R Correa; Patricia Rosa Araujo; Mei Qiao; Suzanne Burns; Luiz O F Penalva; Pedro A F Galante
Journal:  NPJ Genom Med       Date:  2020-01-16       Impact factor: 8.617

2.  Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis.

Authors:  Kathryn A Jacobs; Gwennan André-Grégoire; Clément Maghe; An Thys; Ying Li; Elizabeth Harford-Wright; Kilian Trillet; Tiphaine Douanne; Carolina Alves Nicolau; Jean-Sébastien Frénel; Nicolas Bidère; Julie Gavard
Journal:  EMBO J       Date:  2019-11-27       Impact factor: 11.598

3.  QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.

Authors:  Bo Han; Ruijia Wang; Yongjie Chen; Xiangqi Meng; Pengfei Wu; Ziwei Li; Chunbin Duan; Qingbin Li; Yang Li; Shihong Zhao; Chuanlu Jiang; Jinquan Cai
Journal:  Cell Oncol (Dordr)       Date:  2019-07-10       Impact factor: 6.730

Review 4.  Emerging links between endosomal pH and cancer.

Authors:  Myungjun Ko; Alfredo Quiñones-Hinojosa; Rajini Rao
Journal:  Cancer Metastasis Rev       Date:  2020-06       Impact factor: 9.264

Review 5.  Metabolic heterogeneity and adaptability in brain tumors.

Authors:  Christian E Badr; Daniel J Silver; Florian A Siebzehnrubl; Loic P Deleyrolle
Journal:  Cell Mol Life Sci       Date:  2020-06-06       Impact factor: 9.261

6.  Lysosomes in glioblastoma: pump up the volume.

Authors:  Kathryn A Jacobs; Clément Maghe; Julie Gavard
Journal:  Cell Cycle       Date:  2020-07-29       Impact factor: 4.534

7.  miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells.

Authors:  Junko Mukohyama; Taichi Isobe; Qingjiang Hu; Takanori Hayashi; Takashi Watanabe; Masao Maeda; Hisano Yanagi; Xin Qian; Kimihiro Yamashita; Hironobu Minami; Koshi Mimori; Debashis Sahoo; Yoshihiro Kakeji; Akira Suzuki; Piero Dalerba; Yohei Shimono
Journal:  Cancer Res       Date:  2019-08-15       Impact factor: 12.701

8.  Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype.

Authors:  Yung-Chiang Liu; I-Chi Lee; Pin-Yuan Chen
Journal:  J Neurooncol       Date:  2018-01-22       Impact factor: 4.130

9.  Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα-mediated lipid metabolism.

Authors:  Xin Zhou; Chenxi He; Jiangong Ren; Congxin Dai; Sharon R Stevens; Qianghu Wang; Daniel Zamler; Takashi Shingu; Liang Yuan; Chythra R Chandregowda; Yunfei Wang; Visweswaran Ravikumar; Arvind Uk Rao; Feng Zhou; Hongwu Zheng; Matthew N Rasband; Yiwen Chen; Fei Lan; Amy B Heimberger; Benjamin M Segal; Jian Hu
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

10.  The RNA-binding protein QKI-7 recruits the poly(A) polymerase GLD-2 for 3' adenylation and selective stabilization of microRNA-122.

Authors:  Hiroaki Hojo; Yuka Yashiro; Yuta Noda; Koichi Ogami; Ryota Yamagishi; Shunpei Okada; Shin-Ichi Hoshino; Tsutomu Suzuki
Journal:  J Biol Chem       Date:  2019-12-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.